Loading
Latest filing published 01 Aug 2023 for Spectrum Pharmaceuticals INC. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
This profile gathers the share dealings of Brittany Bradrick across 2 companies, led by Dermata Therapeutics, Inc. and Spectrum Pharmaceuticals Inc. The record holds 5 filings, for trades running from 7 April 2022 to 31 July 2023.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The record was last updated on 1 August 2023 with a transaction in Spectrum Pharmaceuticals Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations